Vanadyl sulfate, a mineral supplement, selectively killed senescent human cells in laboratory experiments and increased median lifespan by 7% in old male mice
Vanadyl sulfate, a mineral supplement, selectively killed senescent human cells in laboratory experiments and increased median lifespan by 7% in old male mice
On November 6, Nature Aging published a paper by University of Chicago researchers who identified vanadyl sulfate in a screen of hundreds of substances circulating in the blood. In human cell cultures, it kills senescent cells, which have stopped dividing and release inflammatory signals, while largely sparing normal cells.
The effects of food on aging remain poorly understood, partly because food has such a complex composition. Jing Chen’s laboratory therefore studies nutrients in the blood, where they are relatively stable and can reach distant organs. The laboratory added 68 dietary supplements to a previously assembled collection of substances. In two rounds of screening, using human cells induced to become senescent by different methods, the researchers looked for substances that killed senescent cells while sparing normal cells. Vanadyl sulfate stood out for its selectivity. It is sold over the counter, and athletes take it to build muscle in the belief that it mimics insulin.
Old male mice (76 weeks of age) received vanadyl sulfate in their drinking water for 13 weeks, while control mice received plain water. Treated mice hung from an inverted grid for longer, gained less fat, responded more strongly to insulin, and had lower blood glucose after glucose administration. Markers of cellular senescence decreased in the liver and kidneys. In young mice given the same substance, endurance, body fat, and blood glucose after glucose administration remained unchanged. In mouse models of diabetes, atherosclerosis, and scarring of the liver and lungs, the substance reduced manifestations of these diseases.
In a separate experiment, 19 old male mice received the substance for three months, starting on day 500 of life. Their median lifespan was 952 days versus 886,5 in 20 control mice.
In cultured senescent cells, vanadyl sulfate oxidizes cysteine residues, amino acids that contain a sulfur atom. Pairs of cysteine residues form disulfide bonds that hold a protein chain in its proper shape. After oxidation, these bonds form between the wrong pairs, causing proteins to clump together. The cell activates autophagy (the breakdown of its own proteins) and, according to the authors’ model, dies when the clumps accumulate faster than it can clear them. Of the two antioxidants tested, only the sulfur-containing N-acetylcysteine protected senescent cells from death. Trolox, which contains no sulfur, did not protect them, although both antioxidants reduced oxidant levels. This points to an effect mediated through cysteine residues.
The authors attribute the selectivity to glutathione. It limits oxidation within the cell by becoming oxidized itself, and the enzyme glutathione reductase restores its active form. In senescent human cells, this enzyme is less active, allowing oxidized glutathione to accumulate. In senescent liver and kidney cells from old mice, the gene encoding the enzyme is less active. When oxidized glutathione was introduced into normal cells, they behaved like senescent cells: they increased their levels of endoplasmic reticulum proteins that form and rearrange disulfide bonds and became more sensitive to vanadyl sulfate. At 12 hours after vanadyl sulfate was added, the clumps in senescent cells were particularly rich in these proteins, linked together by disulfide bonds.
Chen is listed as an inventor on a US patent application covering the use of vanadyl sulfate for age-related diseases and cancer. In the university press release, he explains the effect:
“We start from the idea that aging can be prevented by slowing healthy cells down so they do not wear out. Here, we see that removing senescent cells creates room and opportunities for new cells to replace them, improving overall health.”